Summary
6 Key Take Away Messages
1. High Volume Procedures
Targeting significant market opportunities with widespread procedural demand to maximize clinical and commercial impact. 4.3 M staples sold annually.
2. Clinically Demonstrated Technology
Enhance surgical outcomes validated through 1,000+ procedures in Europe, showing reduce complications, faster, stronger tissue healing.
3. Unique RF Technology
Proprietary algorithm-controlled RF delivery creates consistent, leak-proof tissue connections unlike any other platform.
4. Strong Regulatory Foundation
Original generator received FDA 510 (k) clearance and supports a clearly defined pathway for our new generator.
5. Multiple Products
A robust development pipeline with applications across vessel sealing, anastomosis, and soft tissue welding.
6. Experienced Leadership & Advisors
Led by seasoned executives, industry veterans, and top clinical advisors during innovation and execution.
Disclaimer: The product and procedures depicted above have not been cleared or approved by the U.S. Food and Drug Administration (FDA) and are presented solely for informational purposes. These materials are intended for healthcare professionals and do not constitute promotion or an offer for sale within the United States.
Contacts
- 625 E. Twiggs St., Suite 1000 PMB 99342, Tampa, FL 33602
- info@biofusemedical.com
- 877.466.2434
© BioFuse™ Medical Technologies, Inc. All Right Reserved 2025.
